Data as of Nov 28
| -0.04 / -2.88%|
The 3 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 2.10, with a high estimate of 3.00 and a low estimate of 1.82. The median estimate represents a +55.56% increase from the last price of 1.35.
The current consensus among 3 polled investment analysts is to Buy stock in LifeVantage Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.